OBJECTIVE: To evaluate the impact of vitamin D and parathyroid hormone (PTH) on longitudinal changes in arterial stiffness. APPROACH AND RESULTS: Distensibility coefficient and Young's elastic modulus of the right common carotid artery were evaluated at baseline and after a mean (SD) of 9.4 (0.5) years in 2580 Multi-Ethnic Study of Atherosclerosis (MESA) participants. Cross-sectional and longitudinal associations were evaluated using multivariable linear regression and analysis of covariance. At baseline, participants were 60.1 (9.4) years old (54% female; 26% black, 20% Hispanic, 14% Chinese). Mean annualized 25(OH)D was <20 ng/dL in 816 participants, and PTH was >65 pg/dL in 285 participants. In cross-sectional analyses, low 25(OH)D (<20 ng/mL) was not associated with stiffer arteries after adjustment for cardiovascular disease risk factors (P>0.4). PTH >65 pg/mL was associated with stiffer arteries after adjustment for cardiovascular disease risk factors, other than systolic blood pressure (distensibility coefficient: β=-2.4×10(-4) mm Hg(-1), P=0.003; Young's elastic modulus: β=166 mm Hg, P=0.01); however, after adjustment for systolic blood pressure, these associations no longer were statistically significant. Longitudinal arterial stiffening was associated with older age (P<0.0001), higher systolic blood pressure (P<0.008), and use of antihypertensive medications (P<0.006), but not with 25(OH)D or PTH (both P>0.1). CONCLUSIONS: Carotid arterial stiffness is not associated with low 25(OH)D concentrations. Cross-sectional associations between arterial stiffness and high PTH were attenuated by systolic blood pressure. After nearly a decade of follow-up, neither baseline PTH nor 25(OH)D concentrations were associated with progression of carotid arterial stiffness.
OBJECTIVE: To evaluate the impact of vitamin D and parathyroid hormone (PTH) on longitudinal changes in arterial stiffness. APPROACH AND RESULTS: Distensibility coefficient and Young's elastic modulus of the right common carotid artery were evaluated at baseline and after a mean (SD) of 9.4 (0.5) years in 2580 Multi-Ethnic Study of Atherosclerosis (MESA) participants. Cross-sectional and longitudinal associations were evaluated using multivariable linear regression and analysis of covariance. At baseline, participants were 60.1 (9.4) years old (54% female; 26% black, 20% Hispanic, 14% Chinese). Mean annualized 25(OH)D was <20 ng/dL in 816 participants, and PTH was >65 pg/dL in 285 participants. In cross-sectional analyses, low 25(OH)D (<20 ng/mL) was not associated with stiffer arteries after adjustment for cardiovascular disease risk factors (P>0.4). PTH >65 pg/mL was associated with stiffer arteries after adjustment for cardiovascular disease risk factors, other than systolic blood pressure (distensibility coefficient: β=-2.4×10(-4) mm Hg(-1), P=0.003; Young's elastic modulus: β=166 mm Hg, P=0.01); however, after adjustment for systolic blood pressure, these associations no longer were statistically significant. Longitudinal arterial stiffening was associated with older age (P<0.0001), higher systolic blood pressure (P<0.008), and use of antihypertensive medications (P<0.006), but not with 25(OH)D or PTH (both P>0.1). CONCLUSIONS: Carotid arterial stiffness is not associated with low 25(OH)D concentrations. Cross-sectional associations between arterial stiffness and high PTH were attenuated by systolic blood pressure. After nearly a decade of follow-up, neither baseline PTH nor 25(OH)D concentrations were associated with progression of carotid arterial stiffness.
Authors: Francesco U S Mattace-Raso; Tischa J M van der Cammen; Albert Hofman; Nicole M van Popele; Michiel L Bos; Maarten A D H Schalekamp; Roland Asmar; Robert S Reneman; Arnold P G Hoeks; Monique M B Breteler; Jacqueline C M Witteman Journal: Circulation Date: 2006-02-07 Impact factor: 29.690
Authors: S P Glasser; D K Arnett; G E McVeigh; S M Finkelstein; A J Bank; D J Morgan; J N Cohn Journal: Am J Hypertens Date: 1997-10 Impact factor: 2.689
Authors: John P Forman; Edward Giovannucci; Michelle D Holmes; Heike A Bischoff-Ferrari; Shelley S Tworoger; Walter C Willett; Gary C Curhan Journal: Hypertension Date: 2007-03-19 Impact factor: 10.190
Authors: Judith Hsia; Gerardo Heiss; Hong Ren; Matthew Allison; Nancy C Dolan; Philip Greenland; Susan R Heckbert; Karen C Johnson; JoAnn E Manson; Stephen Sidney; Maurizio Trevisan Journal: Circulation Date: 2007-02-20 Impact factor: 29.690
Authors: Yan Chun Li; Guilin Qiao; Milan Uskokovic; Wei Xiang; Wei Zheng; Juan Kong Journal: J Steroid Biochem Mol Biol Date: 2004-05 Impact factor: 4.292
Authors: Adam D Gepner; Yacob Tedla; Laura A Colangelo; Matthew C Tattersall; Claudia E Korcarz; Joel D Kaufman; Kiang Liu; Gregory L Burke; Steven Shea; Philip Greenland; James H Stein Journal: Hypertension Date: 2016-11-14 Impact factor: 10.190
Authors: Stefan Pilz; Nicolas Verheyen; Martin R Grübler; Andreas Tomaschitz; Winfried März Journal: Nat Rev Cardiol Date: 2016-05-06 Impact factor: 32.419
Authors: Karoline Winckler; Lise Tarnow; Louise Lundby-Christensen; Thomas P Almdal; Niels Wiinberg; Pia Eiken; Trine W Boesgaard Journal: Endocr Connect Date: 2015-05-08 Impact factor: 3.335
Authors: Lasse Oinonen; Antti Tikkakoski; Jenni Koskela; Arttu Eräranta; Mika Kähönen; Onni Niemelä; Jukka Mustonen; Ilkka Pörsti Journal: Endocr Connect Date: 2021-01 Impact factor: 3.335
Authors: Keith C Norris; M Edwina Barnett; Yuan-Xiang Meng; David Martins; Susanne B Nicholas; Gary H Gibbons; Jae Eun Lee Journal: Contemp Clin Trials Date: 2018-07-18 Impact factor: 2.261